![](https://xtacytherapeutics.com/wp-content/uploads/2023/07/XTCY-Featured-Image.png)
XTCY Filing of Annual Financial Statements for Year Ended September 30, 2023
Vancouver April 15, 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“Xtacy Therapeutics” or the “Company”) is pleased to announce that today it